Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 2026
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance
Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou, et al.
Cancers
|
July 2, 2021
Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells
Karolin Walter, Eva Rodriguez-Aznar, Monica S Ventura Ferreira, et al.
Cell Reports. Medicine
|
November 17, 2022
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer
Katrin J Frank, Antonio Mulero-Sánchez, Alexandra Berninger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 2, 2025
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance
Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou, et al.
Journal of Visualized Experiments : Jove
|
June 12, 2023
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Jesús Frutos Díaz-Alejo, Simon April-Monn, Marina Cihova, et al.
Gut
|
September 17, 2016
Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling
Meike Hohwieler, Anett Illing, Patrick C Hermann, et al.
Cancer Research
|
July 3, 2025
PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer
Beatriz Parejo-Alonso, David Barneda, Sara Maria David Trabulo, et al.
Gut
|
September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
Johann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Nature Medicine
|
May 30, 2018
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
Dietrich A Ruess, Guus J Heynen, Katrin J Ciecielski, et al.
Cancer Cell
|
April 13, 2019
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF
María Teresa Blasco, Carolina Navas, Guillermo Martín-Serrano, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
Proceedings of the National Academy of Sciences of the United States of America
|
June 1, 2026
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance
Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou, et al.
Cancers
|
July 2, 2021
Telomerase and Pluripotency Factors Jointly Regulate Stemness in Pancreatic Cancer Stem Cells
Karolin Walter, Eva Rodriguez-Aznar, Monica S Ventura Ferreira, et al.
Cell Reports. Medicine
|
November 17, 2022
Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer
Katrin J Frank, Antonio Mulero-Sánchez, Alexandra Berninger, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 2, 2025
A targeted combination therapy achieves effective pancreatic cancer regression and prevents tumor resistance
Vasiliki Liaki, Sara Barrambana, Myrto Kostopoulou, et al.
Journal of Visualized Experiments : Jove
|
June 12, 2023
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Jesús Frutos Díaz-Alejo, Simon April-Monn, Marina Cihova, et al.
Gut
|
September 17, 2016
Human pluripotent stem cell-derived acinar/ductal organoids generate human pancreas upon orthotopic transplantation and allow disease modelling
Meike Hohwieler, Anett Illing, Patrick C Hermann, et al.
Cancer Research
|
July 3, 2025
PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer
Beatriz Parejo-Alonso, David Barneda, Sara Maria David Trabulo, et al.
Gut
|
September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer
Johann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Nature Medicine
|
May 30, 2018
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
Dietrich A Ruess, Guus J Heynen, Katrin J Ciecielski, et al.
Cancer Cell
|
April 13, 2019
Complete Regression of Advanced Pancreatic Ductal Adenocarcinomas upon Combined Inhibition of EGFR and C-RAF
María Teresa Blasco, Carolina Navas, Guillermo Martín-Serrano, et al.
Page
of 10